Mobile phones do not cause eye cancer

Article

The use of mobile telephones does not increase the risk of uveal melanoma, according to a study published online ahead of print by the Journal of the National Cancer Institute.

The use of mobile telephones does not increase the risk of uveal melanoma, according to a study published online ahead of print by the Journal of the National Cancer Institute.

Andreas Stang, MD, MPH of the Martin Luther University of Halle-Wittenberg, Halle, Germany and colleagues conducted a case-control study of uveal melanoma patients (n=459) and control subjects (n=1194) drawn from the general population, melanoma patients’ siblings and ophthalmologists’ offices. The team used a questionnaire to assess any correlation between melanoma and self-assessed mobile phone use (regular, sporadic and never).

The researchers found that, even among regular mobile telephone users, the incidence of uveal melanoma development was similar to that among the control group: odds ratio (OR) = 0.7, 95% confidence interval (CI) = 0.5 to 1.0 versus population control subjects; OR = 1.1, 95% CI = 0.6 to 2.3 versus ophthalmologist control subjects; and OR = 1.2, 95% CI =0.5 to 2.6 versus sibling control subjects.

Thus the researchers concluded that, up to ten years, mobile telephone use is not correlated with an increased risk of uveal melanoma. This conclusion is in contrast to earlier study results showing a relationship between mobile phone exposure and melanoma development.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
© 2025 MJH Life Sciences

All rights reserved.